113 related articles for article (PubMed ID: 6958672)
1. Cefmetazole (CS-1170): a new cephamycin with activity against gram-negative bacilli and staphylococci.
Benlloch M; Torres A; Soriano F
J Antimicrob Chemother; 1982 Oct; 10(4):347-50. PubMed ID: 6958672
[No Abstract] [Full Text] [Related]
2. In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic.
Tai M; Fukuoka Y; Yotsuji A; Kumano K; Takahata M; Mikami H; Yasuda T; Saikawa I; Mitsuhashi S
Antimicrob Agents Chemother; 1982 Nov; 22(5):728-34. PubMed ID: 6983861
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial activity of cefmetazole compared with those of other cephalosporins.
Schell RF; Kurzynski TA; Le Frock JL; Donato JB
Chemotherapy; 1986; 32(5):431-8. PubMed ID: 3463448
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory and bactericidal activity of cefmetazole and seven other beta-lactams against different bacterial inocula.
Esposito S; Galante D; Barba D
Chemioterapia; 1986 Apr; 5(2):101-4. PubMed ID: 3518963
[TBL] [Abstract][Full Text] [Related]
5. [Experimental studies of cefmetazole in the field of dermatology].
Suwaki M; Kashiwa N; Nohara N
Jpn J Antibiot; 1982 Aug; 35(8):1957-60. PubMed ID: 6961240
[TBL] [Abstract][Full Text] [Related]
6. Comparison of in-vitro activity of cefotetan (ICI 156834), a new cephamycin derivative, with that of cefoxitin.
Chattopadhyay B; Teli JC
J Antimicrob Chemother; 1982 Aug; 10(2):151-4. PubMed ID: 6956565
[No Abstract] [Full Text] [Related]
7. Comparative susceptibilities of organisms isolated in Sicily to cefotetan and other antibiotics.
Russo G; Gismondo MR; Toscano MA; Speciale AM; Nicoletti G
J Antimicrob Chemother; 1983 Jan; 11 Suppl():79-85. PubMed ID: 6573327
[TBL] [Abstract][Full Text] [Related]
8. Semisynthetic cephamycins. II. Structure-activity studies related to cefmetazole (CS-1170).
Nakao H; Yanagisawa H; Ishihara S; Nakayama E; Ando A; Nakazawa J; Shimizu B; Kaneko M; Nagano M; Sugawara S
J Antibiot (Tokyo); 1979 Apr; 32(4):320-9. PubMed ID: 468719
[No Abstract] [Full Text] [Related]
9. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
Matsuo K; Uete T
Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908
[TBL] [Abstract][Full Text] [Related]
10. [Timed bacteriostatic and bactericidal activities of cefmetazole against selected gram-negative bacteria].
Masuda G; Young C; Negishi M; Watanabe T; Yamazaki E; Motegi K
Jpn J Antibiot; 1982 Sep; 35(9):2288-92. PubMed ID: 6754988
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial activity of the cephamycin cefotetan: an in-vitro comparison with other beta-lactam antibiotics.
Clarke AM; Zemcov SJ
J Antimicrob Chemother; 1983 Jan; 11 Suppl():67-72. PubMed ID: 6404881
[TBL] [Abstract][Full Text] [Related]
12. [Experimental and clinical studies of cefmetazole in the field of oral surgery].
Minami Y; Taguchi M; Nanba R; Tsuto H; Yamamoto T; Ueda K; Tsushima T; Morihana T; Nagata K; Nakao K; Shimada K
Jpn J Antibiot; 1982 May; 35(5):1308-21. PubMed ID: 6957626
[TBL] [Abstract][Full Text] [Related]
13. [Cefotetan, a new cephamycin antibiotic: in vitro and in vivo antibacterial activities (author's transl)].
Yano K; Suzaki K; Saito M; Toda M; Naito S; Ohmi Y
Jpn J Antibiot; 1982 Feb; 35(2):438-59. PubMed ID: 6953260
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.
Jones RN; Fuchs PC; Barry AL; Gavan TL; Gerlach EH; Sommers HM
Clin Ther; 1980; 3(Spec Issue):14-23. PubMed ID: 6446389
[No Abstract] [Full Text] [Related]
15. In vitro comparison of cefotetan with five other cephalosporins against nosocomial pathogens.
Daschner FD; Goerke C; Bassler M; Just M
Chemotherapy; 1982; 28(5):351-4. PubMed ID: 6958416
[TBL] [Abstract][Full Text] [Related]
16. In-vitro activity of cefotetan, other beta-lactams and netilmicin.
Shah PM
J Antimicrob Chemother; 1983 Jan; 11 Suppl():73-8. PubMed ID: 6573326
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo antibacterial activities of MT-141, a new semisynthetic cephamycin, compared with those of five cephalosporins.
Inouye S; Goi H; Watanabe T; Hara T; Miyauchi K; Yoshida T; Kazuno Y; Kadosawa H; Hirano F; Kawaharajo K
Antimicrob Agents Chemother; 1984 Nov; 26(5):722-9. PubMed ID: 6440478
[TBL] [Abstract][Full Text] [Related]
18. Cefotetan: profile of in-vitro activity.
Bauernfeind A
J Antimicrob Chemother; 1983 Jan; 11 Suppl():19-29. PubMed ID: 6601656
[TBL] [Abstract][Full Text] [Related]
19. Cefotetan: comparative study in vitro against 226 Gram-negative clinical isolates.
Morel C; Vergnaud M; Langeard MM; Dupuy L
J Antimicrob Chemother; 1983 Jan; 11 Suppl():31-6. PubMed ID: 6573323
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of cefmetazole (CS-1170) and recommendations for susceptibility testing by disk diffusion, dilution, and anaerobic methods.
Jones RN; Barry AL; Fuchs PC; Thornsberry C
J Clin Microbiol; 1986 Dec; 24(6):1055-9. PubMed ID: 3097064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
